These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3217252)

  • 41. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutron capture therapy for melanoma.
    Coderre JA; Glass JD; Micca P; Fairchild RG
    Basic Life Sci; 1989; 50():219-32. PubMed ID: 2751612
    [No Abstract]   [Full Text] [Related]  

  • 43. A post melanosomal era: control of melanogenesis and melanoma growth.
    Mishima Y
    Pigment Cell Res; 1992; Suppl 2():3-16. PubMed ID: 1409434
    [No Abstract]   [Full Text] [Related]  

  • 44. First human clinical trial of melanoma neutron capture. Diagnosis and therapy.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T; Obara H; Shirakawa J; Hiratsuka J; Taniyama K
    Strahlenther Onkol; 1989; 165(2-3):251-4. PubMed ID: 2494743
    [No Abstract]   [Full Text] [Related]  

  • 45. The compound factor of the 10B(n,alpha)7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in boron neutron capture therapy.
    Gabel D; Philipp KH; Wheeler FJ; Huiskamp R
    Radiat Res; 1998 Apr; 149(4):378-86. PubMed ID: 9525503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Boron compounds for neutron capture therapy.
    Alam F; Soloway AH; Bapat BV; Barth RF; Adams DM
    Basic Life Sci; 1989; 50():107-11. PubMed ID: 2751601
    [No Abstract]   [Full Text] [Related]  

  • 47. Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation.
    Ichihashi M; Nakanishi T; Mishima Y
    J Invest Dermatol; 1982 Mar; 78(3):215-8. PubMed ID: 7057053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T
    Pigment Cell Res; 1989; 2(4):226-34. PubMed ID: 2678078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The radiation biology of boron neutron capture therapy.
    Coderre JA; Morris GM
    Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanin-affinic thioureas as selective melanoma seekers.
    Larsson BS
    Melanoma Res; 1991; 1(2):85-90. PubMed ID: 1823628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
    Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-seeking compounds for boron neutron capture therapy: synthesis and biodistribution.
    Gabel D
    Basic Life Sci; 1989; 50():233-41. PubMed ID: 2751613
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute and subacute toxicity of 10B-paraboronophenylalanine.
    Taniyama K; Fujiwara H; Kuno T; Saito N; Shuntoh H; Sakaue M; Tanaka C
    Pigment Cell Res; 1989; 2(4):291-6. PubMed ID: 2798321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutron irradiation of human melanoma cells.
    Brown K; Mountford MH; Allen BJ; Mishima Y; Ichihashi M; Parsons P
    Pigment Cell Res; 1989; 2(4):319-24. PubMed ID: 2798324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases.
    Nano R; Barni S; Gerzeli G; Pinelli T; Altieri S; Fossati F; Prati U; Roveda L; Zonta A
    Ann N Y Acad Sci; 1997 Dec; 832():274-8. PubMed ID: 9704054
    [No Abstract]   [Full Text] [Related]  

  • 57. Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancer.
    Bennett BD; Zha X; Gay I; Morrison GH
    Biol Cell; 1992; 74(1):105-8. PubMed ID: 1511239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific killing of human melanoma cells with an efficient 10B-compound on monoclonal antibodies.
    Komura A; Tokuhisa T; Nakagawa T; Sasase A; Ichihashi M; Ferrone S; Mishima Y
    Pigment Cell Res; 1989; 2(4):259-63. PubMed ID: 2477835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of malignant melanoma by selective thermal neutron capture therapy using melanoma-seeking compound.
    Mishima Y; Ichihashi M; Tsuji M; Hatta S; Ueda M; Honda C; Suzuki T
    J Invest Dermatol; 1989 May; 92(5 Suppl):321S-325S. PubMed ID: 2497193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermal neutron capture therapy: the Japanese-Australian clinical trial for malignant melanoma.
    Allen BJ; Coates AS; McCarthy WH; Mameghan H; Mishima Y; Ichihashi M
    Basic Life Sci; 1989; 50():69-73. PubMed ID: 2665735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.